Showing results (1171-1180 of 1,341) with videos related to

Sort By:
Pageof 135
Bioorganic & Medicinal Chemistry|April 27, 2024
Optimization of benzenesulfonyl derivatives as anti-Trypanosomatidae agents: Structural design, synthesis, and pharmacological assessment against Trypanosoma cruzi and Leishmania infantumGuilherme Freitas de Lima Hercos, Mariza Gabriela Faleiro de Moura Lodi Cruz, Ana Clara Cassiano Martinho, et al.
Veterinary Pathology|November 28, 2007
Equine multinodular pulmonary fibrosis: a newly recognized herpesvirus-associated fibrotic lung diseaseK J Williams, R Maes, F Del Piero, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2004
Illegitimate WNT signaling promotes proliferation of multiple myeloma cellsPatrick W B Derksen, Esther Tjin, Helen P Meijer, et al.
Plos Pathogens|December 16, 2021
Quantification of T-cell dynamics during latent cytomegalovirus infection in humansSara P H van den Berg, Lyanne Y Derksen, Julia Drylewicz, et al.
Arthritis Research & Therapy|August 17, 2017
The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patientsMyrthe A M van Delft, Marije K Verheul, Leonie E Burgers, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 17, 2017
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2βMieke Raap, Malte Gronewold, Henriette Christgen, et al.
Research Involvement and Engagement|January 29, 2026
Establishing a set of acceptable demographic questions for use in health research through public consultationEmma Lidington, Morgaine Stiles, Jessica Maudsley, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 19, 2023
[One Health: a perspective of the informal ministerial network : "What if the One Health approach became the guiding theme of cooperation at the national, European and global level?"]Luzie Verbeek, Denise Rabold, Arne Hartig, et al.
The Lancet. HIV|November 7, 2017
Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trialIngeborg Wijting, Casper Rokx, Charles Boucher, et al.
Pageof 135